India, April 24 -- USFDA conducted an inspection at the Injectable Manufacturing site situated at Jarod, near Vadodara from April 15 to April 23, 2024.
The inspection closed with 10 observations.
The company said that it will closely work with the USFDA to address and respond to the observations in an expeditious manner.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....